[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351972-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-351972-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","dna-methylation-based-classification-of-hematolymphoid-neoplasms","DNA methylation-based classification of hematolymphoid neoplasms","","DNA methylation–based profiling was investigated to improve the classification and diagnostic accuracy of hematolymphoid neoplasms (HLN), addressing the difficulty caused by their morphological heterogeneity. A cross-platform methylome cohort (1156 samples) was analyzed to define 44 reproducible methylation classes aligned with WHO/ICC entities, with copy number alterations inferred for each class. A machine learning classifier achieved 97% concordance in high-confidence cases and showed adjunct value in a subset of discrepant cases, while tumor purity contributed to lower-confidence performance.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dna-methylation-based-classification-of-hematolymphoid-neoplasms/351972/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dna-methylation-based-classification-of-hematolymphoid-neoplasms/351972.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this DNA methylation study in HLN?","Question",{"text":63,"@type":64},"To define DNA methylation classes for hematolymphoid neoplasms and develop a methylation-based machine learning classifier that supports accurate tumor classification and diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were methylation classes derived and how many were identified?",{"text":68,"@type":64},"A cross-platform HLN methylome cohort (1156 samples) was used to identify 44 reproducible methylation classes that closely match WHO/ICC-defined entities, including clinically and biologically relevant subgroups.",{"name":70,"@type":61,"acceptedAnswer":71},"How accurate was the machine learning classifier?",{"text":72,"@type":64},"The classifier showed 97% concordance with the original diagnosis in high-confidence cases, with a modest 58% high-confidence score rate.",{"name":74,"@type":61,"acceptedAnswer":75},"What factors affected classifier confidence and how could discordant cases be handled?",{"text":76,"@type":64},"Tumor purity contributed to a substantial proportion of low-confidence samples. In discrepant high-confidence cases, additional review revised diagnoses in favor of methylation predictions in most cases (5/8).","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},351972,1790494636,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","REGULAR ARTICLE  \nDNA methylation-based classification of hematolymphoid neoplasms  \nAnnapurna Saksena,1,* Christin Siewert,2, 3,* Rust Turakulov,1 Omkar Singh,1 Zied Abdullaev,1 Ting Zhou, 1 Jeremiah Karrs,1  \nJoao Victor Alves De Castro, 1 Deanna Riley, 1 Shannon Skarshaug, 1 Valerie Zgonc,1 Lana Sultanaeva,1 Ruifeng Teng,1 Liqiang Xi, 1 Robert J. Kreitman,4 Andreas von Deimling,5 Martí Duran-Ferrer,6 Jos´e Ignacio Martín-Subero,6, 7 Elias Campo,6, 8 Benjamin Englert,9 Julia Richter, 10 Wolfram Klapper, 10 Ioannis Anagnostopoulos,11 Andreas Rosenwald, 11 Marion Wobser, 12 Falko Fend, 13  \nLeticia Quintanilla-Martinez,13 Gerardo Ferrer, 14 Manel Esteller, 14-17 Miguel A. Piris, 18 Michael Hummel, 19 Stefania Pittaluga, 1 Mark Raffeld,1 Elaine S. Jaffe, 1 David Capper,2, 3,† and Kenneth Aldape 1,†  \n1 Laboratory of Pathology, National Cancer Institute, Bethesda, MD; 2 Department of Neuropathology, Berlin Institute of Health, Charit´e-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; 3 German Cancer Consortium, Partner Site Berlin, German Cancer Research Center, Heidelberg, Germany; 4 Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD; 5 Department of Neuropathology, Institute of Pathology, University Hospital of Heidelberg, Heidelberg, Germany; 6 Institut d’Investigacions Biom`ediques August Pi I Sunyer, Barcelona, Spain; 7 Instituci´o Catalana de Recerca i Estudis Avançats, Barcelona, Spain; 8 Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; 9 Department of Pathology, University of Helsinki, Helsinki, Finland; 10 Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts-University of Kiel, University-Hospital Schleswig-Holstein, Kiel, Germany;  \n11 Pathologisches Institut, Universität Würzburg, Würzburg, Germany; 12 Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany; 13 Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany; 14Josep Carreras Leukaemia Research Institute, Badalona, Spain; 15 Centro de Investigaci´on Biom´edica en Red C´ancer, Madrid, Spain; 16 Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Spain; 17 Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; and 18 Pathology Service, Fundaci´on Jim´enez Díaz, Madrid, Spain; and 19 Charit´e - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and HumboldtUniversität zu Berlin, Institut für Pathologie, Molekularpathologie, Berlin, Germany  \nKey Points  \n• This study defines DNA methylation classes in >1400 HLN, correlating with known entities and revealing key subgroups.  \n• Machine learning– based classifier, as proof of concept for future clinical tool, showed 97% diagnostic concordance in highconfidence cases.  \nAccurate pathologic diagnosis of hematolymphoid neoplasms (HLN) is often challenging because of their complexity and heterogeneity. Genome-wide DNA methylation profiling has emerged as a valuable tool for tumor classification and diagnosis across malignancies, such as central nervous system neoplasms. In this study, we explored the role of DNA methylation– based profiling in HLN. We generated the largest crossplatform HLN methylome cohort to date (1156 samples) and identified 44 reproducible methylation classes (MCs) that aligned closely with entities defined by the 5th edition of the World Health Organization (WHO) Classification/the International Consensus Classification (ICC), including subgroups with clinical and biological relevance. Copy number alterations were also inferred for all MCs. Additionally, a machine learning–based DNA methylation classifier was developed and validated on an independent test set, demonstrating a modest 58% high-conf","cbCaivoHiBt57768","https://ap.wps.com/l/cbCaivoHiBt57768","pdf",6350881,18,"English","# Key Points\n## Study aims and diagnostic challenge\n## DNA methylation profiling and methylation classes\n## Machine learning classifier performance\n## Factors affecting confidence and future utility","[{\"question\":\"What is the main goal of this DNA methylation study in HLN?\",\"answer\":\"To define DNA methylation classes for hematolymphoid neoplasms and develop a methylation-based machine learning classifier that supports accurate tumor classification and diagnosis.\"},{\"question\":\"How were methylation classes derived and how many were identified?\",\"answer\":\"A cross-platform HLN methylome cohort (1156 samples) was used to identify 44 reproducible methylation classes that closely match WHO/ICC-defined entities, including clinically and biologically relevant subgroups.\"},{\"question\":\"How accurate was the machine learning classifier?\",\"answer\":\"The classifier showed 97% concordance with the original diagnosis in high-confidence cases, with a modest 58% high-confidence score rate.\"},{\"question\":\"What factors affected classifier confidence and how could discordant cases be handled?\",\"answer\":\"Tumor purity contributed to a substantial proportion of low-confidence samples. In discrepant high-confidence cases, additional review revised diagnoses in favor of methylation predictions in most cases (5/8).\"}]","DNA methylation-based classification of hematolymphoid neoplasms | PDF",1790096639,45,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/404a4efe3249ea9f5596c839df08a5a4.webp",983,1296,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bcfea81826d8d61792bd4f2bf75d729.webp",982,1294,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6afe6db725a5db637087b86f94ff7539.webp",981,1293,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea120ba21825139714d0f7933f16bcab.webp",980,1292]